左心室辅助装置植入后结局的性别差异
基于美国全国住院患者样本分析2009至2014年3511例(加权17251例)左心室辅助装置(LVAD)植入患者,女性占23.32%。女性LVAD植入量翻倍但男性仍为女性3倍;男女住院死亡率(13.42% vs 12.85%;OR 1.05;P=.16)及围术期并发症无显著差异。
要点
- 女性LVAD植入量增加但性别差距仍存在,男性植入为女性3倍
- 男女住院死亡率及围术期并发症发生率无显著差异
- 常见并发症为急性肾损伤、需输血出血及术后脓毒症
核心结论
- 连续流LVAD时代女性植入量增加但性别差距仍存在,多数院内结局两性相似。
研究设计与样本
- 基于美国全国住院患者样本的回顾性分析,纳入2009至2014年3511例(加权17251例)LVAD植入患者,女性817例(23.32%),平均年龄56岁。
主要发现
- 女性LVAD植入从2009至2014年翻倍,但男性植入仍为女性3倍。
- 住院死亡率女性13.42%、男性12.85%(OR 1.05;P=.16),无显著差异。
- 围术期并发症(心包填塞、血栓栓塞、脓毒症)、住院时间、住院费用中位数及ECMO使用无性别差异。
- 65岁以上亚组院内死亡率更高但无性别差异。
关键数值与推荐
- 住院死亡率:女性13.42% vs 男性12.85%;OR 1.05;P=.16。
- 女性占研究样本23.32%(817/3511),加权总例数17251。
- 男性LVAD植入为女性3倍;女性植入量2009至2014年翻倍。
临床怎么用
- 女性LVAD植入后院内结局与男性相近,选择候选者时不应因性别差异影响决策。
局限性
- 为回顾性住院样本分析,非随机对照设计,摘要未报告其他局限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Left ventricular assist device (LVAD) implantation has historically been underutilized in women compared with men. It was hypothesized that the introduction of continuous-flow LVADs would lead to more LVAD implantations in women and possibly narrow the gender gap. METHODS: Patients who underwent LVAD implantation between 2009 and 2014 were identified using the national inpatient sample. RESULTS: A total of 3511 patients (17,251 when weighted) underwent LVAD implantation in the United States between 2009 and 2014. Mean age was 56 years and there were 817 women in the study sample (23.32%). LVAD implantations in women doubled from 2009 to 2014, but men continued to receive LVAD 3 times more than women. Inpatient mortality after LVAD placement was similar between men and women (13.42% women vs 12.85% men; odds ratio, 1.05; P = .16). Most common complications after LVAD implantation in both genders included acute kidney injury, bleeding requiring blood transfusion, and postoperative sepsis. There were no gender-specific differences in the incidence of periprocedural complications, including postoperative cardiac tamponade, postoperative thromboembolism, or sepsis. In addition, no significant difference was found in length of stay and median hospitalization cost. The use of extracorporeal membrane oxygenation did not differ between men and women. Subgroup analysis in patients older than 65 years of age showed higher in-hospital mortality but no differences between genders. CONCLUSIONS: The number of women undergoing LVAD implantation has increased with the introduction of continuous-flow LVADs, but a gender gap still exists. Most major in-hospital outcomes after LVAD implantation are similar between genders.
引用
- Ahmed A, Adegbala O, Akintoye E, et al. Gender Differences in Outcomes After Implantation of Left Ventricular Assist Devices. Ann Thorac Surg. 2019. PMID: 31479642. doi:10.1016/j.athoracsur.2019.07.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。